ONCO — Oncopeptides AB Share News
0.000.00%
Last trade - 00:00- SEK665.09m
- SEK642.65m
- SEK71.12m
Brief: Oncopeptides Q3 Operating Profit SEK -36.47 Million
Brief: Oncopeptides Completes Directed Share Issue Of SEK 100 Mln
Brief: Oncopeptides Confirms Blood-Brain-Barrier Penetration In Glioblastoma Study
Swedish biotech Oncopeptides' Q2 net sales rise on strong demand in Italy
Brief: Oncopeptides Q2 Operating Profit SEK -48.668 Million
Brief: Oncopeptides Gets List Price For Pepaxti In Slovenia
Brief: Oncopeptides Submits Type II Variation Application To EMA
Brief: Oncopeptides Signs Distribution Agreement With Salus
Brief: Oncopeptides Publishes Phase 2 Bridge Study Results In Clinical Lymphoma, Myeloma, Leukemia
Brief: Oncopeptides: Regulatory Approval To Start Window-Of-Opportunity Study In Glioblastoma
Oncopeptides Q1 sales jump 91% on demand for Pepaxti in Italy
Brief: Oncopeptides Q1 Operating Profit SEK -37.531 Million
Brief: Oncopeptides Intends To Submit Type II Variation Application
Brief: Oncopeptides Secures Fast-Track Designation In Glioblastoma
Brief: Oncopeptides Suggests No Dividend For 2025
Brief: Oncopeptides Q4 Net Sales Increase By 88% Y-o-Y
Sweden's Oncopeptides Q4 sales rise 88%
Brief: Oncopeptides Announces Share Issue Of About SEK 200 Mln
Brief: Oncopeptides Expects Q4 Net Sales Of SEK 18.6 Mln